Greenwich LifeSciences Provides Update on Phase III Clinical Trial, Flamingo-01
GlobeNewswire
STAFFORD, Texas, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage..
STAFFORD, Texas, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage..
WESTPORT, Conn., Nov. 30, 2020 (GLOBE NEWSWIRE) -- HMG Strategy, the world's #1 digital platform for connecting technology..